A Phase 1, Two-Part, Open-Label, Parallel-Cohort, Single-Dose Study to Determine the Pharmacokinetics of T-817MA in Adult Subjects With Hepatic Impairment and in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 22 May 2017
At a glance
- Drugs Edonerpic (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors Toyama Chemical
- 16 May 2017 Status changed from active, no longer recruiting to completed.
- 09 Sep 2016 Status changed from recruiting to active, no longer recruiting.
- 06 Apr 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.